Status:
COMPLETED
The Effect of Kombucha on Blood Sugar Levels in Humans
Lead Sponsor:
University of Missouri-Columbia
Conditions:
Glucose
Glucose Metabolism Disorders (Including Diabetes Mellitus)
Eligibility:
All Genders
30-65 years
Phase:
NA
Brief Summary
As a phase 0 clinical trial, we will learn how kombucha influences glucose metabolism in humans.
Detailed Description
Consumption of kombucha, a fermented tea beverage, has been promoted for a wide range of health benefits. However, a systematic literature review (Kapp \& Sumner, 2019) revealed a lack of evidence for...
Eligibility Criteria
Inclusion
- Men or women ages 30-65 years old
- English-speaking
- Have transportation to campus
- Overweight (BMI \>= 25 kg/m2) or obese (BMI \>=30 kg/m2)
Exclusion
- Currently use any type of nicotine product
- A diagnosis of any of the following:
- Diabetes (type 1 or 2)
- Cancer
- COPD
- Chronic alcoholism
- Peripheral vascular disease
- Autoimmune disease
- Chronic kidney disease
- Pregnant or breastfeeding
- Prescribed medication for insulin, glucose-lowering drugs, or steroids, such as prednisone
- Have routinely taken prebiotic or probiotic supplements in the past 3 months
- Have routinely consumed any of the following more than one time per week in the past month: kombucha, kefir, yogurt, kimchi, cottage cheese, raw apple cider vinegar (with the "mother"), sauerkraut, kvass.
Key Trial Info
Start Date :
January 3 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 30 2022
Estimated Enrollment :
33 Patients enrolled
Trial Details
Trial ID
NCT04051294
Start Date
January 3 2019
End Date
September 30 2022
Last Update
September 8 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Missouri
Columbia, Missouri, United States, 65212